// App-Quantinova.ai

M2076 2016 AHA : Treatment Persistence With New Oral Anticoagulants for Non-Valvular Atrial Fibrillation: The Quebec Observational Study

Researchers

Presenter

  • Janie Coulombe

Principal Investigators

  • Thomas Evers

  • Christel Renoux

Medical Centers

  • McGill University, Jewish General Hospital, Montreal, QC, Canada

Locations

  • Canada

Companies

  • Bayer

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Non-valvular atrial fibrillation

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Warfarin

  • Grace

Outcome

  • N/A

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved